Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma

Cancer Letters

Volumn 103, Issue 1, 1996, Pages 1-9

  Jarnicki, Andrew G ^a,d   Fitzpatrick, David R ^a,b   Robinson, Bruce W S ^a   Bielefeldt Ohmann, Helle ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Immunodeviation; TGF ; Tumor infiltrating lymphocytes

Indexed keywords

CD3 ANTIGEN; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; IMMUNOSURVEILLANCE; MESOTHELIOMA; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0029965245     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04178-X     Document Type: Article

References (33)

1. Bielefeldt-Ohmann, H., Fitzpatrick, D.R., Marzo, A.L., Jarnicki, A.G., Musk, A.W. and Robinson, B.W.S. (1995) The potential for interferon-α based therapy in mesothelioma: assessment in a murine model. J. Interferon Cytokine Res., 15, 213-223.
2. Bielefeldt-Ohmann, H., Marzo, A.L., Himbeck, R.P., Jarnicki, A.G., Robinson, B.W.S. and Fitzpatrick, D.R. (1995) Interleukin-6 involvement in mesothelioma: inhibition by interferon-α immunotherapy. Cancer Immunol. Immunother., 40, in press.
3. Bielefeldt-Ohmann, H., Fitzpatrick, D.R., Marzo, A.L., Jarnicki, A.G., Himbeck, R.P., Davis, M.R., Manning, L.S. and Robinson, B.W.S. (1994) Patho- and immunobiology of malignant mesothelioma: characterisation of tumor infiltrating leukocytes and cytokine production in a murine model. Cancer Immunol. Immunother., 39, 347-359.
4. Bucy, R.P., Panoskaltsis-Mortari, A., Huang G.-q., Li, J., Karr, L., Ross, M., Russell, J.H., Murphy K.M. and Weaver, C.T. (1994) Heterogeneity of single cell cytokine gene expression in clonal T cell populations. J. Exp. Med., 180, 1251-1262.
5. Buferne, M., Luton, F. and Letourneur F. (1992) Role of CD3δ in surface expression of the TCR/CD3 complex and in activation for killing analyzed with a CD3δ-negative cytotoxic T lymphocyte variant. J. Immunol., 148, 657-664.
6. Clayton, L.K., D'Adamio, L., Howard, F.D., Sieh, M., Hussey, R.E., Koyasu, S. and Reinherz, E.L. (1991) CD3η and CD3ζ are alternatively spliced products of a common genetic locus and are transcriptionally and/or post-transcriptionally regulated during T-cell development. Proc. Natl. Acad. Sci. USA, 88, 5202-5206.
7. Clevers, H., Alarcon, B., Wileman, T. and Terhorst, C. (1988) The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu. Rev. Immunol., 6, 629-662.
8. + T lymphocytes. Intern. Immunol., 6, 631-638.
9. DeSilva, D.R., Urdahl, K.B. and Jenkins, M.K. (1991) Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol., 147, 3261-3267.
10. Doskow, J.R. and Wilkinson, M.F. (1992) CD3-γ, -δ, -ξ, T-cell receptor-α and -β transcripts are independently regulated during thymocyte ontogeny and T-cell activation. Immunology, 77, 465-468.
11. Farace, F., Angevin, E., Vanderplancke, J., Escudier, B. and Triebel, F. (1994) The decreased expression of CD3ζ chains in cancer patients is not reversed by IL-2 administration. Int. J. Cancer, 59, 752-755.
12. Fargeas, C., Wu, C., Nakajima, T., Cox, D., Nutman, T. and Delespesse, G. (1992) Differential effect of TGFβ on the synthesis of TH1 and TH2-like lymphokines by human T lymphocytes. Eur. J. Immunol., 22, 2173-2176.
13. Finke, J.H., Zea, A.H., Stanley, J., Hart, L., Alexander, J.P., Edinger, M.G., Tubbs, R.R., Klein, E., Tuason, L. and Bukowski, R.M. (1993) Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res., 53, 5613-5616.
14. Fitzpatrick, D.R., Bielefeldt-Ohmann, H., Himbeck, R.P., Jarnicki, A.G., Marzo, A.L. and Robinson, B.W.S. (1994) Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and T-cell infiltration in malignant mesothelioma. Growth Factors, 11, 29-44.
15. Fitzpatrick, D.R., Peroni, D. and Bielefeldt-Ohmann, H. (1995) The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma. Am. J. Resp. Cell Mol. Biol., in press.
16. Kedar, E. and Klein, E. (1992) Cancer immunotherapy: are the results discouraging? Can they be improved? Adv. Cancer Res., 59, 245-322.
17. LaSalle, J.M., Tolentino, P.J., Freeman, G.J., Nadler, L.M. and Hafler, D.A. (1992) Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J. Exp. Med., 176, 177-186.
18. Miescher, S., Stoeck, M., Whiteside, T.L., Leyvraz, S., Ruzicka, J., Schindler, A.M., Givel, J.C., Mosimann, F. and von Fliedner, V. (1991) Altered activation pathways in T lymphocytes infiltrating human solid tumors. Cancer Immunol. Immunother. 32, 280-288.
19. Mizoguchi, H., O'Shea, J.J., Longo, D.L., Loeffler, C., McVicar, W. and Ochoa, A. (1992) Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science, 258, 1795-1797.
20. Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J.C., Vivier, E., Anderson, P. and Kiessloing, R. (1993) Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res., 53, 5620-5612.
21. Orchansky, P.L. and Teh, H.S. (1994) Activation-induced cell death in proliferating T cells is associated with altered tyrosine phosphorylation of TCR/CD3 subunits. J. Immunol., 153, 615-622.
22. Robert, A.B. and Sporn, M.B. (1993) Physiological actions and clinical applications of transforming growth factor-β. Growth Factors, 8, 1-9.
23. Sambrook, I., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Press, Cold Spring Harbor, NY, pp. 9.38-9.40.
24. Schall, T.J., O'Hehir, R.E., Goeddel, D.V. and Lamb, J.R. (1992) Uncoupling of cytokine mRNA expression and protein secretion during the induction phase of T cell anergy. J. Immunol., 148, 381-387.
25. Shores, E.W., Huang, K., Tran, T., Lee, E., Grinberg, A. and Love, P.E. (1994) Role of TCRβ chain in T cell development and selection. Science, 266, 1047-1050.
26. Tada, T., Ohzeki, S., Utsumi, K., Takiuchi, H., Muramatsu, M., Li, X-F., Shimizu, J., Fujiwara, H. and Hamaoka, T. (1991) Transforming growth factor-β-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J. Immunol., 146, 1077-1082.
27. Troutt, A.B., Maraskovsky, E., Rogers, L.A., Pech, M.H. and Kelso, A. (1992) Quantitative analysis of lymphokine expression in vivo and in vitro. Immunol. Cell Biol., 70, 51-57.
28. Vangsted, A., Neisig, A., Wallin, H., Zeuthen, J. and Geisler, C. (1993) Induction of CD3δ, ε, ω by phorbol 12-myristate 13-acetate. Eur. J. Immunol., 23, 1351-1357.
29. Vose, B.M. and Moore, M. (1985) Human tumor-infiltrating lymphocytes. Semin. Hematol., 22, 27-40.
30. Weiss, A., Imboden, J., Hardy, K., Manger, B., Terhorst, C. and Stobo, J. (1986) The role of the T3/antigen receptor complex in T-cell activation. Annu. Rev. Immunol., 4, 593-619.
31. Wilbanks, G.A. and Streilein, J.W. (1992) Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β. Eur. J. Immunol., 22, 1031-1036.
32. Yano, T., Yasumoto, K., Togami, M., Ishida, T., Kimura, G., Sugimachi, K. and Nomoto, K. (1989) Properties of recombinant interleukin 2-cultured-tumor-infiltrating lymphocytes in human lung cancer. Int. J. Cancer, 43, 619-623.
33. Zanders, E.D., Lamb, J.R., Feldmann, M., Green, N. and Beverley, P.C.L. (1983) Tolerance of T-cell clones is associated with membrane antigen changes. Nature, 303, 625-627.